About

Crysalis Biosciences is an advanced biomanufacturing and technology company focused on developing and operating sustainable biochemical production facilities. The company specializes in the design, development, and operation of integrated bioprocessing plants that produce low-carbon biofuels, renewable chemicals, and industrial solvents using proprietary technologies and renewable feedstocks. Headquartered in Columbus, Georgia with operations in Sauget, Illinois, the company is committed to revitalizing U.S. chemical manufacturing infrastructure by converting existing industrial assets into modern biorefineries capable of producing next-generation sustainable fuels and biochemicals. Crysalis Biosciences’ flagship project in Sauget involves the redevelopment of a former ethanol facility into a state-of-the-art biorefinery designed to produce sustainable aviation fuel (SAF) and low-carbon chemical products. This facility leverages advanced fermentation, conversion, and refining technologies to deliver fuels and industrial products with significantly lower carbon intensity than traditional fossil-derived alternatives. Through its integrated approach to biotechnology, process engineering, and industrial operations, Crysalis Biosciences aims to accelerate the global transition toward low-carbon energy systems while strengthening domestic manufacturing capacity and supporting the growing demand for sustainable fuels and chemicals.